CTSO: CytoSorbents reports 1st quarter 2024 financial results and highlighted STAR-T trial data p..._老虎社区_美港股上老虎

CTSO: CytoSorbents reports 1st quarter 2024 financial results and highlighted STAR-T trial data p...

Smartkarma
2024-05-16

⬆ $CytoSorbents (CTSO)$ - CytoSorbents is commercializing its E.U. approved CytoSorb blood purification technology to treat life-threatening conditions in the intensive...

Continue reading on Smartkarma:- https://www.smartkarma.com/insights/ctso-cytosorbents-reports-1st-quarter-2024-financial-results-and-highlighted-star-t-trial-data-presentation-at-the-aats-conference?utm_source=tiger_community

By Zacks Small Cap Research, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/zacks-small-cap-research?utm_source=tiger_community

On CytoSorbents (CTSO):- https://www.smartkarma.com/entities/cytosorbents-corp?utm_source=tiger_community

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":306353400053784,"tweetId":"306353400053784","gmtCreate":1715799764000,"gmtModify":1715806782612,"author":{"id":4103332230805300,"idStr":"4103332230805300","authorId":4103332230805300,"authorIdStr":"4103332230805300","name":"Smartkarma","avatar":"https://static.tigerbbs.com/bb92df7ff435380d798b36afa44a5c07","vip":5,"userType":5,"introduction":"Smartkarma官方账号","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":340,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"CTSO: CytoSorbents reports 1st quarter 2024 financial results and highlighted STAR-T trial data p...","html":"<html><head></head><body> \n⬆ $CytoSorbents (CTSO)$ - CytoSorbents is commercializing its E.U. approved CytoSorb blood purification technology to treat life-threatening conditions in the intensive...\n \nContinue reading on Smartkarma:- https://www.smartkarma.com/insights/ctso-cytosorbents-reports-1st-quarter-2024-financial-results-and-highlighted-star-t-trial-data-presentation-at-the-aats-conference?utm_source=tiger_community\nBy Zacks Small Cap Research, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/zacks-small-cap-research?utm_source=tiger_community\nOn CytoSorbents (CTSO):- https://www.smartkarma.com/entities/cytosorbents-corp?utm_source=tiger_community</body></html>","htmlText":"<html><head></head><body> \n⬆ $CytoSorbents (CTSO)$ - CytoSorbents is commercializing its E.U. approved CytoSorb blood purification technology to treat life-threatening conditions in the intensive...\n \nContinue reading on Smartkarma:- https://www.smartkarma.com/insights/ctso-cytosorbents-reports-1st-quarter-2024-financial-results-and-highlighted-star-t-trial-data-presentation-at-the-aats-conference?utm_source=tiger_community\nBy Zacks Small Cap Research, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/zacks-small-cap-research?utm_source=tiger_community\nOn CytoSorbents (CTSO):- https://www.smartkarma.com/entities/cytosorbents-corp?utm_source=tiger_community</body></html>","text":"⬆ $CytoSorbents (CTSO)$ - CytoSorbents is commercializing its E.U. approved CytoSorb blood purification technology to treat life-threatening conditions in the intensive... Continue reading on Smartkarma:- https://www.smartkarma.com/insights/ctso-cytosorbents-reports-1st-quarter-2024-financial-results-and-highlighted-star-t-trial-data-presentation-at-the-aats-conference?utm_source=tiger_community By Zacks Small Cap Research, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/zacks-small-cap-research?utm_source=tiger_community On CytoSorbents (CTSO):- https://www.smartkarma.com/entities/cytosorbents-corp?utm_source=tiger_community","highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/306353400053784","repostId":0,"isVote":1,"tweetType":1,"viewCount":27326,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["CTSO"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":615,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}